<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0001428'>Somatic mutations</z:hpo> of DNMT3A gene have recently been reported in <z:hpo ids='HP_0004808'>acute myeloid leukemia</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>) and <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) </plain></SENT>
<SENT sid="1" pm="."><plain>We examined the entire coding sequences of DNMT3A gene by high-resolution melting analysis and sequencing in Chinese patients with <z:e sem="disease" ids="C0027022" disease_type="Neoplastic Process" abbrv="MPD">myeloid malignancies</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>R882 mutations were found in 12/182 AML and in 4/51 MDS, but not in either 79 <z:hpo ids='HP_0011010'>chronic</z:hpo> myeloid <z:hpo ids='HP_0001909'>leukemia</z:hpo> (<z:mp ids='MP_0005481'>CML</z:mp>), or 57 myeloproliferative <z:hpo ids='HP_0002664'>neoplasms</z:hpo> (MPNs), or 4 <z:hpo ids='HP_0011010'>chronic</z:hpo> monomyelocytic <z:hpo ids='HP_0001909'>leukemia</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>No other DNMT3A mutations were detected in <z:hpo ids='HP_0000001'>all</z:hpo> patients </plain></SENT>
<SENT sid="4" pm="."><plain>R882 mutations were associated with old age and more frequently present in monoblastic <z:hpo ids='HP_0001909'>leukemia</z:hpo> (M4 and M5, 7/52) compared to other subtypes (5/130) </plain></SENT>
<SENT sid="5" pm="."><plain>Furthermore, 14/16 (86.6%) R882 mutations were observed in patients with <z:mpath ids='MPATH_458'>normal</z:mpath> karyotypes </plain></SENT>
<SENT sid="6" pm="."><plain>The overall survival of mutated <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> patients was shorter than those without mutation (median 9 and 25 months, respectively) </plain></SENT>
<SENT sid="7" pm="."><plain>We conclude that DNMT3A R882 mutations are recurrent molecular aberrations in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>, and may be an adverse prognostic event in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> </plain></SENT>
</text></document>